Mahindra Manulife Large Cap Fund - Direct Plan -Growth

Mahindra Manulife Large Cap Fund - Direct Plan -Growth sits in the middle of the pack for Large Cap funds, currently carrying a 3-star rating. It has delivered steady, if unspectacular, returns over a full market cycle. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 64/100.

Cost: At 1.05%, the expense ratio runs 36% above the Large Cap category average of 0.77%. That gap is worth weighing against the fund's actual performance versus cheaper peers before committing to a long SIP.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a negative Sharpe ratio of -0.65 — over the past year, returns haven't kept pace with the volatility involved, even before accounting for the risk-free rate. Separately, annualised volatility of 12.87% is fairly typical for actively managed equity funds.

Who should invest: This fund is best suited to conservative equity investors or those wanting a stable core holding, typically with a 3+ year horizon. The High risk rating means near-term volatility should be expected — this isn't a fund to check daily.